Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Randomized, Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

NCT05159427 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT05159427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Randomized, Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers
Lead sponsor
University of Michigan
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2022
Completion date
March 29, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human gastrointestinal physiology data